- Home
- BNZI vs QNTM Comparison
BNZI vs QNTM Comparison
Compare BNZI & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- QNTM
- Stock Information
- Founded
- BNZI 2016
- QNTM 1998
- Country
- BNZI United States
- QNTM Canada
- Employees
- BNZI N/A
- QNTM N/A
- Industry
- BNZI
- QNTM
- Sector
- BNZI
- QNTM
- Exchange
- BNZI Nasdaq
- QNTM NYSE
- Market Cap
- BNZI 9.5M
- QNTM 9.1M
- IPO Year
- BNZI N/A
- QNTM N/A
- Fundamental
- Price
- BNZI $1.55
- QNTM $5.10
- Analyst Decision
- BNZI Strong Buy
- QNTM
- Analyst Count
- BNZI 1
- QNTM 0
- Target Price
- BNZI $125.00
- QNTM N/A
- AVG Volume (30 Days)
- BNZI 1.1M
- QNTM 66.2K
- Earning Date
- BNZI 11-14-2024
- QNTM 11-12-2024
- Dividend Yield
- BNZI N/A
- QNTM N/A
- EPS Growth
- BNZI N/A
- QNTM N/A
- EPS
- BNZI N/A
- QNTM N/A
- Revenue
- BNZI $4,310,782.00
- QNTM N/A
- Revenue This Year
- BNZI $23.28
- QNTM N/A
- Revenue Next Year
- BNZI $66.99
- QNTM N/A
- P/E Ratio
- BNZI N/A
- QNTM N/A
- Revenue Growth
- BNZI N/A
- QNTM N/A
- 52 Week Low
- BNZI $1.46
- QNTM $3.50
- 52 Week High
- BNZI $828.50
- QNTM $96.20
- Technical
- Relative Strength Index (RSI)
- BNZI 33.35
- QNTM 49.64
- Support Level
- BNZI $1.56
- QNTM $4.75
- Resistance Level
- BNZI $1.82
- QNTM $5.35
- Average True Range (ATR)
- BNZI 0.23
- QNTM 0.45
- MACD
- BNZI 0.02
- QNTM -0.04
- Stochastic Oscillator
- BNZI 8.65
- QNTM 32.64
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.